Case study with ValiRx (AIM:VAL)

• ValiRx is a clinical-stage life sciences company developing therapeutics for cancer and women's health. Its investor base spans retail shareholders, specialist biotech investors and healthcare-focused funds, a community that expects regular, substantive updates and has very specific questions about pipeline progress. InvestorHub has become the company's primary channel for delivering that level of engagement at scale.

"Like a lot of AIM biotech companies, our investor communication was fragmented. RNS went out, we updated our website periodically, and we did occasional investor events. But there was no single place where an investor could come and find everything in one place, the latest news, our pipeline, presentations, share price information.

The Hub has given us that destination. We now have somewhere we can point people to that genuinely reflects the company as it is today, not as it was six months ago when we last updated the corporate site."

Your pipeline involves quite technical science, VAL201, VAL301, Inaphaea BioLabs. How do you use the platform to make that accessible?

"The updates function has been really valuable for this. Alongside our formal announcements, we publish regular content updates that explain what's happening in the pipeline in plain terms. That might be a summary of what a trial phase means in practice, or context around a partnering agreement we've signed. It sits separately from the RNS but is linked to it, so investors get the technical disclosure and the explanation side by side.

We've also found that the Q&A functionality helps us understand where the gaps are in our communications. If we're getting the same question about a particular compound repeatedly, that tells us we need to do a better job explaining it."

Mark Eccleston

CEO @ ValiRx

About ValiRx

Industry: Clinical-stage biotechnology (oncology and women's health) Market: AIM (LSE: VAL)

InvestorHub Products: Hub, Newsflow, Webinars, Audience, Investor Q&A

By submitting your email address and any other personal information to this website, you consent to such information being collected, held, used and disclosed in accordance with our privacy policy and our website terms and conditions.